Smoking And Dementia: New Research Points To Rare Lung Cells As A Missing Link

Smoking is one of the most well-established risk factors for dementia, yet the biological path connecting a cigarette to cognitive decline has never been fully mapped. A new study may have found a missing piece. Rare cells deep in the airways that, when exposed to nicotine, appear to ship iron-loaded molecular packages directly to neighboring nerve cells, setting off a chain of cellular stress that researchers say could help explain how smoking harms the brain.

Published in Science Advances, the research centers on a little-known cell type called pulmonary neuroendocrine cells, or PNECs. Making up less than 1% of all lung cells, PNECs sit at a uniquely important crossroads: wired directly to nerve fibers that feed into the vagus nerve, the major highway connecting the lungs to the brain. Atrophy of that nerve has previously been linked to dementia. When exposed to nicotine, PNECs pump out tiny bubble-like packages called exosomes at nearly three times the normal rate, packages loaded with an iron-carrying protein that appears to increase iron uptake in nearby nerve cells, reduce their energy levels, and raise signs of cellular stress associated with neurodegenerative disease.

What makes this pathway notable is its directness. Rather than nicotine simply circulating through the bloodstream and gradually wearing down brain tissue, this research points to a local, cell-to-cell delivery system operating in the lungs themselves, alongside other known pathways, one that could be quietly amplifying neurological risk with every puff.

Smoking and Dementia: Why Rare Lung Cells May Be Part of the Answer

Studying PNECs has long frustrated researchers. Because they’re so rare, isolating enough from human tissue for lab experiments is extremely difficult. To get around this, the team used human stem cells to grow their own PNECs in the lab, calling them “induced PNECs” or iPNECs. Using a carefully staged process, scientists coaxed stem cells through several developmental phases, mimicking how the lung forms during embryonic growth, until a portion matured into functional PNECs.

To confirm these lab-grown cells were authentic, the team ran gene-level analyses comparing them to native PNECs from actual human lungs. iPNECs carried the same identity markers, produced the same chemical messengers, and had the molecular machinery involved in iron processing. With a reliable supply in hand, researchers could finally begin testing what happens when nicotine enters the picture.

Nicotine Triggers a Surge of Iron-Laden Packages

When iPNECs were exposed to nicotine, exosome release jumped 2.8-fold compared to untreated cells. More telling than the quantity was the cargo. Protein analysis revealed the exosomes were enriched with serotransferrin, a protein that grabs iron and shuttles it into cells. Further testing confirmed serotransferrin was being released mainly through exosomes rather than floating loosely into the surrounding fluid.

When these nicotine-triggered exosomes were introduced to nerve cells in the lab, iron storage protein built up, energy production fell, oxidative stress spiked, and mitochondria, the power plants inside every cell, showed reduced function. Perhaps most provocatively, the nerve cells showed elevated levels of alpha-synuclein, a protein linked to Parkinson’s disease. Separately, mice injected with the same nicotine-triggered exosomes showed signs of brain inflammation and scored worse on a memory test measuring whether animals can distinguish between familiar and new objects.

Blocking the Iron Door

Researchers then asked a critical follow-up question: could they stop the damage by cutting off the iron supply? Using a compound called ferristatin-II, which blocks the protein that acts as a doorway for iron entering cells, the team treated nerve cells alongside the nicotine-triggered exosomes. Iron storage levels dropped, energy production recovered, and oxidative stress improved. A genetic approach that silenced the same iron-doorway gene produced similar protective results.

Blocking exosome release from PNECs altogether, and silencing the serotransferrin gene, also reduced downstream nerve cell damage, reinforcing that the exosomes and their iron-binding cargo are central to the sequence of events.

What Smokers’ Lungs Reveal About the Smoking and Dementia Connection

To check whether laboratory observations held up in real tissue, the team examined lung samples from human smokers and nonsmokers, as well as from mice given nicotine. In smokers’ lungs, PNECs were more abundant, and gene activity tied to exosome production and iron regulation was elevated. Nerve cells near PNECs showed higher levels of the same iron transporters seen in lab experiments.

Lung tissue from a mouse model of neurodegeneration showed elevated alpha-synuclein in lung neurons compared to healthy mice. Gene expression analyses of Alzheimer’s disease brain data showed patterns similar to those seen in neurodegenerative disease datasets, consistent with the iron-handling and oxidative stress signatures identified in the lung experiments.

None of the tissue and animal findings prove causation on their own. Researchers acknowledge that future experiments blocking exosome release or iron delivery in living animals are needed to confirm whether this pathway truly contributes to dementia risk. Still, a targeted compound already reversing iron overload and oxidative stress in nerve cells raises the possibility, still untested, that future therapies might protect smokers’ brains while the harder work of helping people quit gets underway.

---

Disclaimer: This article is based on a single laboratory study published in Science Advances. Findings from cell and animal experiments do not establish that this mechanism causes dementia or brain disease in humans. No clinical conclusions should be drawn from this research at this stage.

---